Indivior Pharmaceuticals INDV
NASDAQ INDV
$38.19 -0.85 (-2.18%)
At close: Aug 20, 2026 · 1:46 PM UTC

Indivior Pharmaceuticals (INDV) EBIT Margin (2024 - 2026)

Indivior Pharmaceuticals (INDV) posted quarterly EBIT Margin of 43.22% for Q1 2026, up 1841.0% year-over-year from 2.23% in Q1 2025, and up 91.01% quarter-over-quarter from 22.63% in Q4 2025.

Indivior Pharmaceuticals (INDV) EBIT Margin (2024 - 2026) Analysis & Trends

Indivior Pharmaceuticals' EBIT Margin history runs 3 years deep, the most recent figure standing at 43.22% for Q1 2026.

  • In Q1 2026, EBIT Margin rose 1841.0% year-over-year to 43.22%; the TTM figure through Mar 2026 stood at 25.79% (up 2332.0% YoY), while the FY2025 annual figure was 21.15%, up 1795.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 43.22%, up from 22.63% in the prior quarter.
  • The five-year high for EBIT Margin was 43.22% in Q1 2026, with the low at 39.46% in Q2 2024.
  • The 3-year median for EBIT Margin is 22.63% (2025), against an average of 15.77%.
  • Peak annual rise in EBIT Margin reached 6331 bps in 2025, while the deepest fall reached 160 bps in 2025.
  • Indivior Pharmaceuticals' EBIT Margin stood at 15.38% in 2024, then surged by 47 bps to 22.63% in 2025, then jumped by 91 bps to 43.22% in 2026.
  • Business Quant data shows INDV's EBIT Margin at 43.22% in Q1 2026, 22.63% in Q4 2025, and 13.69% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn -5.58%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 33.91%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 16.51%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 42.23%
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn 0.17%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 15.80%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 18.13%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Indivior Pharmaceuticals 4.54 Bn 4.32 Bn 294.00 Mn 46.65%

Historic Data

Download Data
DateValue
Jun 30, 2026 46.65%
Mar 31, 2026 43.22%
Dec 31, 2025 22.63%
Sep 30, 2025 13.69%
Jun 30, 2025 23.84%
Mar 31, 2025 24.81%
Dec 31, 2024 15.38%
Sep 30, 2024 11.40%
Jun 30, 2024 -39.46%
Mar 31, 2024 26.41%